Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit H Mulsant

Showing results (401-410 of 607) with videos related to

Pageof 61
Sort By:
Bipolar Disorders|June 17, 2011
Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary reportMartha Sajatovic, Ariel Gildengers, Rayan K Al Jurdi, et al.
Journal of Psychiatry & Neuroscience : JPN|October 29, 2020
Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapyJennifer I Lissemore, Benoit H Mulsant, Tarek K Rajji, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Bipolar Disorders|September 10, 2021
Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysisClare Cullen, Nils Kappelmann, Madeha Umer, et al.
Journal of Substance Use and Addiction Treatment|November 8, 2023
A computer-assisted telephone collaborative care intervention provided by lay providers for the treatment of comorbid depression and at-risk drinking: Analysis of a randomized controlled trialHelena K Kim, Osnat C Melamed, Matthew Sloan, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
International Journal of Geriatric Psychiatry|May 26, 2017
Assessing bipolar disorder in the older adult: the GERI-BD toolboxPatricia Marino, Herbert C Schulberg, Ariel G Gildengers, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Bipolar Disorders|December 24, 2010
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adultsAriel G Gildengers, Benoit H Mulsant, Rayan K Al Jurdi, et al.
Pageof 61

Showing results (401-410 of 607) with videos related to

Sort By:
Pageof 61
Bipolar Disorders|June 17, 2011
Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary reportMartha Sajatovic, Ariel Gildengers, Rayan K Al Jurdi, et al.
Journal of Psychiatry & Neuroscience : JPN|October 29, 2020
Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapyJennifer I Lissemore, Benoit H Mulsant, Tarek K Rajji, et al.
Journal of Alzheimer'S Disease : JAD|January 31, 2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive ImpairmentJun Ku Chung, Eric Plitman, Shinichiro Nakajima, et al.
Bipolar Disorders|September 10, 2021
Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysisClare Cullen, Nils Kappelmann, Madeha Umer, et al.
Journal of Substance Use and Addiction Treatment|November 8, 2023
A computer-assisted telephone collaborative care intervention provided by lay providers for the treatment of comorbid depression and at-risk drinking: Analysis of a randomized controlled trialHelena K Kim, Osnat C Melamed, Matthew Sloan, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
International Journal of Geriatric Psychiatry|May 26, 2017
Assessing bipolar disorder in the older adult: the GERI-BD toolboxPatricia Marino, Herbert C Schulberg, Ariel G Gildengers, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Bipolar Disorders|December 24, 2010
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adultsAriel G Gildengers, Benoit H Mulsant, Rayan K Al Jurdi, et al.
Pageof 61